These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 28448568

  • 1. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E, Samuel W, Duncan T, Gutierrez DB, Mata NL, Redmond TM.
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [Abstract] [Full Text] [Related]

  • 2. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL.
    Clin Cancer Res; 2003 Oct 01; 9(12):4606-13. PubMed ID: 14555536
    [Abstract] [Full Text] [Related]

  • 3. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues.
    Vratilova J, Frgala T, Maurer BJ, Patrick Reynolds C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep 05; 808(2):125-30. PubMed ID: 15261805
    [Abstract] [Full Text] [Related]

  • 4. Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide.
    Rahmaniyan M, Curley RW, Obeid LM, Hannun YA, Kraveka JM.
    J Biol Chem; 2011 Jul 15; 286(28):24754-64. PubMed ID: 21543327
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG, Appierto V, Cavadini E, Valsecchi M, Sonnino S, Curley RW, Formelli F.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture.
    Mehta RG, Hultin TA, Moon RC.
    Biochem J; 1988 Dec 01; 256(2):579-84. PubMed ID: 2851995
    [Abstract] [Full Text] [Related]

  • 12. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
    Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS, Lippman SM.
    Clin Cancer Res; 2003 Jul 01; 9(7):2400-5. PubMed ID: 12855611
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
    Song MM, Makena MR, Hindle A, Koneru B, Nguyen TH, Verlekar DU, Cho H, Maurer BJ, Kang MH, Reynolds CP.
    Anticancer Drugs; 2019 Feb 01; 30(2):117-127. PubMed ID: 30272587
    [Abstract] [Full Text] [Related]

  • 16. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N, Sausville EA, Breitman TR.
    Clin Cancer Res; 1995 Jun 01; 1(6):637-42. PubMed ID: 9816026
    [Abstract] [Full Text] [Related]

  • 17. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
    Hultin TA, McCormick DL, May CM, Moon RC.
    Drug Metab Dispos; 1988 Jun 01; 16(6):783-8. PubMed ID: 2907453
    [Abstract] [Full Text] [Related]

  • 18. Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity.
    Appierto V, Tiberio P, Cavadini E, Casalini P, Cappelletti G, Formelli F.
    Mol Cancer Ther; 2009 Dec 01; 8(12):3360-8. PubMed ID: 19996280
    [Abstract] [Full Text] [Related]

  • 19. Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.
    Cho HE, Min HK.
    J Pharm Biomed Anal; 2017 Jan 05; 132():117-124. PubMed ID: 27701038
    [Abstract] [Full Text] [Related]

  • 20. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
    Swanson BN, Newton DL, Roller PP, Sporn MB.
    J Pharmacol Exp Ther; 1981 Dec 05; 219(3):632-7. PubMed ID: 6170750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.